Dockets Entered On 05/29/2003
Docket # Title
1995N-0304
Ephedrine Alkaloids: Reports of Adverse Events; Availability
1998P-0680
Amend reg re: sale & distribution of turtles & viable eggs
2000N-1571
Enrofloxacin for Poultry: Opportunity for Hearing
2002N-0475
Financial Relationships & Interest in Research Involving Hum
2002P-0171
Misbranding of regulated drugs by third Parties
2002P-0426
Andrx in its currently pending ANDA 76-159 Glipizide product
2002P-0469
ANDA for Brimonidine Tartrate Ophthalmic Solution 0.2%
2003D-0092
Food and Cosmetic Security Guidances
2003N-0069
FDA Task Force on Consumer Health Info for Better Nutrition
C
4028 American Assn of Oriental Medicine (AAOM) Vol #: 374
1996N-0417 CGMP in Mfg. Packing or Holding
Dietary Supplements
C 111 Bill Brandt Vol #: 7
C 112 Thomas E. Platz Vol #: 7
C 113 Jim Barton Vol #: 7
PDN
1 HFC-1 to Richard J. Fife Vol #: 1
2000N-1571
Enrofloxacin for Poultry: Opportunity for Hearing
CS
43 HFA-305 Vol #: 377
OR
45 HF-3 Vol #: 377
2001P-0075 Switch Status of Emergency Contraceptives
from Rx to OTC
C 283 Kathy Palm Jorgensen, APRN Vol #:
38
2002D-0324 Bioengineered Plants for Use
in Humans and Animals
C 644 Barbara-Jean Avery Vol #: 13
2002H-0443 Civil Money Penalty Re: LaHaye
Ctr.for Advanced Eye Care
CS 10 HFA-305 Vol #: 1
OR 8 HF-3 Vol #: 1
2002N-0204 Bar Code Label Requirements
for human drug products
EC 60 Haskins, Doug Vol #: 17
EC 61 brown, michael Vol #: 17
2002N-0276 Bioterrorism Preparedness;Registration
of Food Facilities
C 158 Seafreeze Ltd Partnership Vol #:
13
C
5 Duke University Medical Center Vol #: 1
C
6 Assn of Clinical Research Organizatios (ACRO) Vol #: 1
C
7 American Medical Assn Vol #: 1
C
8 Tufts University Vol #: 1
2002N-0528 Risk Management Workshop, April
9-11, 2003 [PDUFA III]
NEC 1 FDA Vol #: 3
PDN
1 HFC-1 to Gene Koprowski Vol #: 1
LET
1 HFD-5 to Andrx Pharmaceuticals, Inc. Vol #: 1
PDN
1 HFD-1 to Fish & Richardson, PC Vol #: 1
C
3 Nutraceutical Corporation Vol #: 1
2003D-0167 Draft Guidance: Dispute Resolution Procedures-Science-based
Decisions on Products CVM regulates
GDL 1 Draft Guidance Vol #: 1
NAD 1 FDA Vol #: 1
C
1 American Medical Assn Vol #: 1
C
2 AARP Vol #: 2
2003N-0169 Dental Amalgam; Request for Information
N 2 FDA Vol #: 1
|
